• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Fast Radius Expands Leadership Team and Appoints New General Counsel and Chief Accounting Officer

    3/15/22 8:00:00 AM ET
    $BAX
    $CNHI
    $FSRD
    $GRPN
    Medical/Dental Instruments
    Health Care
    Construction/Ag Equipment/Trucks
    Industrials
    Get the next $BAX alert in real time by email

    CHICAGO, March 15, 2022 (GLOBE NEWSWIRE) -- Fast Radius, Inc. (NASDAQ:FSRD), a cloud manufacturing company, today announced it has named Erin Stone as General Counsel and Corporate Secretary, and James Erkenswick as Chief Accounting Officer. These leadership additions mark important milestones for Fast Radius' evolution as a publicly traded company. In her capacity as General Counsel and Corporate Secretary, Stone will serve as an important strategic and legal advisor to Fast Radius's board of directors and management and will oversee all legal and compliance matters for the company. In his role as Chief Accounting Officer, Erkenswick will have leadership over the preparation of all financial accounting, audit and internal controls matters, and the preparation of Fast Radius's external reporting materials.

    "Erin and Jim bring invaluable experience leading corporate governance and compliance for fast-growing, public companies, bringing additional expertise and leadership as we continue to scale our business in the near-term," said Lou Rassey, Co-Founder and CEO of Fast Radius. "They both possess an entrepreneurial spirit and proven cross-functional leadership ability. We are thrilled to have them join the Fast Radius leadership team."

    Stone has more than 15 years of legal experience working with technology-driven businesses and public companies. Prior to Fast Radius, Stone served as Vice President and Deputy General Counsel, Corporate and Securities at Groupon (NASDAQ:GRPN), where she was a key advisor and trusted partner to their executive team and Board of Directors. She also brings strong technical expertise in corporate governance and securities, and broad commercial experience from her tenure at Groupon and as a corporate partner at Winston and Strawn LLP.

    As Chief Accounting Officer, Erkenswick brings more than 20 years of accounting and finance experience for industrial companies, with deep knowledge of SEC reporting and GAAP compliance. Most recently, Erkenswick served as Vice President, Assistant Controller at Baxter International Inc. (NYSE:BAX), where he held positions leading financial reporting and corporate accounting. Prior to joining Baxter International, Erkenswick held accounting leadership positions at US LBM, CNH Industrial (NYSE:CNHI), and Ace Hardware.

    ABOUT FAST RADIUS

    Fast Radius, Inc. is a leading cloud manufacturing and digital supply chain company. The Fast Radius Cloud Manufacturing Platform™ provides software applications and manufacturing solutions that help engineers design, make, and fulfill commercial-grade parts, when and where they are needed. This enables companies to manufacture and ship parts easily, flexibly, and sustainably. Founded in 2017, Fast Radius, Inc. is headquartered in Chicago with offices in Atlanta, Louisville, and Singapore, and microfactories in Chicago and at the UPS Worldport facility in Louisville, KY. To learn more about Fast Radius and how its digital manufacturing capabilities are helping companies, please visit www.fastradius.com or connect with us on LinkedIn at www.linkedin.com/company/fastradius or Twitter @fastradius.

    CONTACT

    Kelly Smith

    MSL U.S.

    [email protected];

    646-500-7654



    Primary Logo

    Get the next $BAX alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BAX
    $CNHI
    $FSRD
    $GRPN

    CompanyDatePrice TargetRatingAnalyst
    Baxter International Inc.
    $BAX
    8/4/2025$25.00Buy → Hold
    Stifel
    Baxter International Inc.
    $BAX
    8/1/2025$25.00Buy → Neutral
    Goldman
    Baxter International Inc.
    $BAX
    2/26/2025$42.00Buy
    Goldman
    Baxter International Inc.
    $BAX
    2/24/2025Hold → Buy
    Argus
    Baxter International Inc.
    $BAX
    2/20/2025$39.00Overweight
    Barclays
    Baxter International Inc.
    $BAX
    7/15/2024$39.00 → $30.00Equal-Weight → Underweight
    Morgan Stanley
    Groupon Inc.
    $GRPN
    7/10/2024$22.00Outperform
    Northland Capital
    Baxter International Inc.
    $BAX
    5/30/2024$36.00Neutral
    Goldman
    More analyst ratings

    $BAX
    $CNHI
    $FSRD
    $GRPN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 18, 2024 - FDA Roundup: October 18, 2024

    For Immediate Release: October 18, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  This week, FDA continues ongoing efforts to increase access and supply of IV and peritoneal dialysis (PD) fluids following Hurricane Helene-related damage to Baxter International Inc.’s facility in Marion, North Carolina. Specifically, FDA acted quickly to c

    10/18/24 4:16:25 PM ET
    $NVCR
    $BAX
    Medical/Dental Instruments
    Health Care

    $BAX
    $CNHI
    $FSRD
    $GRPN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO Senkypl Dusan converted options into 109,250 shares, increasing direct ownership by 16% to 773,011 units (SEC Form 4)

    4 - Groupon, Inc. (0001490281) (Issuer)

    8/13/25 5:04:45 PM ET
    $GRPN
    Advertising
    Consumer Discretionary

    Chief Financial Officer Ponrt Jiri converted options into 40,968 shares and covered exercise/tax liability with 18,149 shares, increasing direct ownership by 14% to 188,895 units (SEC Form 4)

    4 - Groupon, Inc. (0001490281) (Issuer)

    8/13/25 4:58:25 PM ET
    $GRPN
    Advertising
    Consumer Discretionary

    Director Bass Robert J sold $96,660 worth of shares (3,055 units at $31.64), decreasing direct ownership by 3% to 101,676 units (SEC Form 4)

    4 - Groupon, Inc. (0001490281) (Issuer)

    8/13/25 4:22:19 PM ET
    $GRPN
    Advertising
    Consumer Discretionary

    $BAX
    $CNHI
    $FSRD
    $GRPN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Groupon Reports Second Quarter 2025 Results

    Global Revenue up 1% and Billings up 12%North America Local Revenue up 3% and Local Billings up 20%Completion of $244 million Financing TransactionChicago, Illinois--(Newsfile Corp. - August 6, 2025) - Groupon, Inc. (NASDAQ:GRPN) today announced its financial results for the second quarter ended June 30, 2025. The company filed its Form 10-Q with the Securities and Exchange Commission and posted updated earning commentary on its investor relations website (investor.groupon.com)."Our Q2 results demonstrate that Groupon's transformation is gaining real momentum, with 20% Billings growth in North America Local and accelerating customer acquisition across our core local category," said Dusan Sen

    8/6/25 4:19:00 PM ET
    $GRPN
    Advertising
    Consumer Discretionary

    CNH Industrial N.V. Reports Second Quarter 2025 Results

    Second quarter consolidated revenues were $4.7 billion on lower industry demand Second quarter diluted EPS at $0.17 Results reflect continued execution of cost saving initiatives partially offsetting market headwinds Returned $0.3 billion to shareholders through dividends Full-year guidance reaffirmed Basildon, UK - August 1, 2025 - CNH Industrial N.V. (NYSE:CNH) today reported results for the three months ended June 30, 2025, with net income of $217 million and diluted earnings per share of $0.17 compared with net income of $404 million and diluted earnings per share of $0.32 for the three months ended June 30, 2024(1). Consolidated revenues were $4.71 billion (down 14% compared to Q2

    8/1/25 6:30:00 AM ET
    $CNH
    $CNHI
    Construction/Ag Equipment/Trucks
    Industrials

    Baxter Reports Second-Quarter 2025 Results

    Second-quarter sales from continuing operations of $2.81 billion increased 4% on a reported basis and 1% on an operational basis, in line with the company's previously issued guidance1,2 Second-quarter U.S. GAAP3 diluted earnings per share (EPS) from continuing operations of $0.24; adjusted diluted EPS from continuing operations of $0.59, in line with the company's previously issued guidance Recently announced appointment of Andrew Hider as president and chief executive officer (CEO)4 supports company's focus to accelerate innovation, drive sustainable growth, enhance operational effectiveness and create shareholder value Baxter International Inc. (NYSE:BAX), a global medtech lead

    7/31/25 7:15:00 AM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    $BAX
    $CNHI
    $FSRD
    $GRPN
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Groupon Inc.

    SCHEDULE 13G/A - Groupon, Inc. (0001490281) (Subject)

    8/13/25 4:14:53 PM ET
    $GRPN
    Advertising
    Consumer Discretionary

    Groupon Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Groupon, Inc. (0001490281) (Filer)

    8/6/25 4:12:40 PM ET
    $GRPN
    Advertising
    Consumer Discretionary

    SEC Form 10-Q filed by Groupon Inc.

    10-Q - Groupon, Inc. (0001490281) (Filer)

    8/6/25 4:12:00 PM ET
    $GRPN
    Advertising
    Consumer Discretionary

    $BAX
    $CNHI
    $FSRD
    $GRPN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Harinstein Jason bought $159,150 worth of shares (15,000 units at $10.61), increasing direct ownership by 37% to 55,658 units (SEC Form 4)

    4 - Groupon, Inc. (0001490281) (Issuer)

    8/9/24 4:38:58 PM ET
    $GRPN
    Advertising
    Consumer Discretionary

    Senkypl Dusan bought $3,069,745 worth of shares (323,344 units at $9.49) (SEC Form 4)

    4 - Groupon, Inc. (0001490281) (Issuer)

    11/20/23 6:27:56 PM ET
    $GRPN
    Advertising
    Consumer Discretionary

    $BAX
    $CNHI
    $FSRD
    $GRPN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Baxter downgraded by Stifel with a new price target

    Stifel downgraded Baxter from Buy to Hold and set a new price target of $25.00

    8/4/25 8:18:58 AM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    Baxter downgraded by Goldman with a new price target

    Goldman downgraded Baxter from Buy to Neutral and set a new price target of $25.00

    8/1/25 8:11:11 AM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    Goldman resumed coverage on Baxter with a new price target

    Goldman resumed coverage of Baxter with a rating of Buy and set a new price target of $42.00

    2/26/25 7:01:30 AM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    $BAX
    $CNHI
    $FSRD
    $GRPN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Groupon Inc.

    SC 13G - Groupon, Inc. (0001490281) (Subject)

    12/13/24 10:39:00 AM ET
    $GRPN
    Advertising
    Consumer Discretionary

    SEC Form SC 13G filed by Groupon Inc.

    SC 13G - Groupon, Inc. (0001490281) (Subject)

    12/6/24 2:12:18 PM ET
    $GRPN
    Advertising
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Groupon Inc.

    SC 13G/A - Groupon, Inc. (0001490281) (Subject)

    11/14/24 6:51:01 PM ET
    $GRPN
    Advertising
    Consumer Discretionary

    $BAX
    $CNHI
    $FSRD
    $GRPN
    Financials

    Live finance-specific insights

    View All

    Groupon Reports Second Quarter 2025 Results

    Global Revenue up 1% and Billings up 12%North America Local Revenue up 3% and Local Billings up 20%Completion of $244 million Financing TransactionChicago, Illinois--(Newsfile Corp. - August 6, 2025) - Groupon, Inc. (NASDAQ:GRPN) today announced its financial results for the second quarter ended June 30, 2025. The company filed its Form 10-Q with the Securities and Exchange Commission and posted updated earning commentary on its investor relations website (investor.groupon.com)."Our Q2 results demonstrate that Groupon's transformation is gaining real momentum, with 20% Billings growth in North America Local and accelerating customer acquisition across our core local category," said Dusan Sen

    8/6/25 4:19:00 PM ET
    $GRPN
    Advertising
    Consumer Discretionary

    CNH Industrial N.V. Reports Second Quarter 2025 Results

    Second quarter consolidated revenues were $4.7 billion on lower industry demand Second quarter diluted EPS at $0.17 Results reflect continued execution of cost saving initiatives partially offsetting market headwinds Returned $0.3 billion to shareholders through dividends Full-year guidance reaffirmed Basildon, UK - August 1, 2025 - CNH Industrial N.V. (NYSE:CNH) today reported results for the three months ended June 30, 2025, with net income of $217 million and diluted earnings per share of $0.17 compared with net income of $404 million and diluted earnings per share of $0.32 for the three months ended June 30, 2024(1). Consolidated revenues were $4.71 billion (down 14% compared to Q2

    8/1/25 6:30:00 AM ET
    $CNH
    $CNHI
    Construction/Ag Equipment/Trucks
    Industrials

    Baxter Reports Second-Quarter 2025 Results

    Second-quarter sales from continuing operations of $2.81 billion increased 4% on a reported basis and 1% on an operational basis, in line with the company's previously issued guidance1,2 Second-quarter U.S. GAAP3 diluted earnings per share (EPS) from continuing operations of $0.24; adjusted diluted EPS from continuing operations of $0.59, in line with the company's previously issued guidance Recently announced appointment of Andrew Hider as president and chief executive officer (CEO)4 supports company's focus to accelerate innovation, drive sustainable growth, enhance operational effectiveness and create shareholder value Baxter International Inc. (NYSE:BAX), a global medtech lead

    7/31/25 7:15:00 AM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    $BAX
    $CNHI
    $FSRD
    $GRPN
    Leadership Updates

    Live Leadership Updates

    View All

    Baxter Appoints Andrew Hider Chief Executive Officer

    Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced the appointment of Andrew Hider as president and chief executive officer (CEO), and a member of its board of directors. Mr. Hider will assume his responsibilities at Baxter no later than Sept. 3, 2025, or an earlier date pending completion of his current employment commitments. Brent Shafer, who has served as chair and interim CEO since February 2025, will then transition to independent chair of the Baxter Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250706840140/en/Andrew Hider Appointed Baxter's Next CEO Since 2017, Mr. Hider has served as

    7/7/25 8:35:00 AM ET
    $ATS
    $BAX
    Industrial Machinery/Components
    Industrials
    Medical/Dental Instruments
    Health Care

    Amerant Bancorp Announces Appointment of Two New Board Members

    Amerant Bancorp Inc. (NYSE:AMTB) ("Amerant" or "the Company") and its subsidiary, Amerant Bank, N.A. (the "Bank"), today announced the appointment of two accomplished executives, Patricia "Patty" Morrison and Jack Kopnisky, to the Board of Directors of the Company and the Bank. Their addition reflects the Company's continued commitment to strategic growth and further strengthening of the Board of Directors and executive management. "We are delighted to welcome both Patty and Jack to our Board of Directors," said Jerry Plush, Chairman and CEO of Amerant and the Bank. "Patty's deep technology leadership and extensive board expertise, paired with Jack's enviable experience in leading high pe

    6/24/25 9:20:00 AM ET
    $AMTB
    $BAX
    $WBS
    Major Banks
    Finance
    Medical/Dental Instruments
    Health Care

    CNH announces Global Leadership Team appointment

    CNH announces Global Leadership Team appointment Basildon, March 17, 2025 CNH (NYSE:CNH) today announces the appointment of Cameron Batten as Chief Communications Officer effective March 31, 2025. Mr. Batten will join the Company's Global Leadership Team (GLT), which is empowered to carry out the fast and effective delivery of CNH's strategic priorities for profitable long-term growth. Cameron Batten has over 25 years of experience in communications across media and institutional/government relations, brand marketing, corporate reputation, employee engagement and social impact with top-tier consumer brands. Ahead of joining CNH, he served as Chief Communications Officer at Volkswage

    3/17/25 4:30:00 PM ET
    $CNH
    $CNHI
    Construction/Ag Equipment/Trucks
    Industrials